GRN and early-onset autosomal dominant Alzheimer disease: Numerous studies have shown that down-regulation of GRN expression is associated with inflammation in multiple neurodegenerative diseases such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's disease and Parkinson's disease (26).